Table 4.
Minimal visual loss | Mild visual loss | Moderate visual loss | Severe visual loss | P value | |
---|---|---|---|---|---|
Total number of eyes | 95 | 71 | 62 | 20 | |
Simple CSCR | 58 (61.1%) | 37 (52.1%) | 15 (24.2%) | 2 (10%) | <0.001a |
Complex CSCR | 37 (38.9%) | 33 (46.5%) | 44 (71%) | 17 (85%) | <0.001b |
Atypical CSCR | 0 | 1 (1.4%) | 3 (4.8%) | 1 (5%) | 0.025b |
Primary CSCR | 75 (78.9%) | 55 (77.5%) | 41 (66.1%) | 15 (75%) | 0.16 |
Recurrent CSCR | 16 (16.8%) | 15 (21.1%) | 15 (24.2%) | 3 (15%) | 0.55 |
Resolved CSCR | 4 (4.2%) | 1 (1.4%) | 6 (9.7%) | 2 (10%) | 0.1 |
Persistent SRF | 15 (15.8%) | 12 (17%) | 25 (40.3%) | 9 (45%) | 0.001b |
ORA + | 25 (26.3%) | 28 (39.4%) | 44 (71%) | 15 (75%) | <0.001b |
Fovea+ | 86 (90.5%) | 70 (98.6%) | 59 (95.2%) | 18 (90%) | 0.5 |
MNV + | 4 (4.2%) | 6 (8.5%) | 6 (9.7%) | 3 (15%) | 0.07 |
asignificant trend towards minimal visual loss.
bsignificant trend towards severe visual loss.
Minimal visual loss: visual acuity ≥ 20/25 Snellen equivalent; Mild visual loss: Visual acuity ≥ 20/40 and <20/25; Moderate visual loss: visual acuity ≥ 20/100 and < 20/40; Severe visual loss: visual acuity < 20/100; CSCR: central serous chorioretinopathy; SRF: subretinal fluid; ORA + : outer retinal atrophy present; Fovea + : foveal involvement present for subretinal fluid/ pigment epithelial detachment/ outer retinal atrophy; MNV + : macular neovascularization present.